ATE42306T1 - 21-substituierte thiosteroide. - Google Patents

21-substituierte thiosteroide.

Info

Publication number
ATE42306T1
ATE42306T1 AT86108656T AT86108656T ATE42306T1 AT E42306 T1 ATE42306 T1 AT E42306T1 AT 86108656 T AT86108656 T AT 86108656T AT 86108656 T AT86108656 T AT 86108656T AT E42306 T1 ATE42306 T1 AT E42306T1
Authority
AT
Austria
Prior art keywords
sup
group
carbon atoms
substituted
thiosteroids
Prior art date
Application number
AT86108656T
Other languages
English (en)
Inventor
Morihiro Mitsukuchi
Tomoyuki Ikemoto
Yoshiaki Watanabe
Kaoru Sota
Original Assignee
Jouveinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal Sa filed Critical Jouveinal Sa
Application granted granted Critical
Publication of ATE42306T1 publication Critical patent/ATE42306T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Dowels (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
AT86108656T 1985-06-26 1986-06-25 21-substituierte thiosteroide. ATE42306T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13927685 1985-06-26
EP86108656A EP0208202B1 (de) 1985-06-26 1986-06-25 21-Substituierte Thiosteroide

Publications (1)

Publication Number Publication Date
ATE42306T1 true ATE42306T1 (de) 1989-05-15

Family

ID=15241512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86108656T ATE42306T1 (de) 1985-06-26 1986-06-25 21-substituierte thiosteroide.

Country Status (6)

Country Link
US (1) US4861765A (de)
EP (1) EP0208202B1 (de)
JP (1) JPH0699468B2 (de)
AT (1) ATE42306T1 (de)
DE (1) DE3662896D1 (de)
ES (1) ES8707256A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344651A (en) * 1993-07-23 1994-09-06 The Procter & Gamble Company Cyproterone acetate thioacetate
US5439901A (en) * 1993-07-23 1995-08-08 The Procter & Gamble Company Cyproterone thiopivalate
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
SI1775305T1 (sl) * 2000-08-05 2015-01-30 Glaxo Group Limited S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
KR100831534B1 (ko) * 2001-04-30 2008-05-22 글락소 그룹 리미티드 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2512987C (en) 2003-01-21 2011-06-14 Merck & Co., Inc. 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1945240B1 (de) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Zusammensetzungen mit rezeptor-assoziierten protein (rap) varianten, die für cr-haltige proteine spezifisch sind und ihre verwendungen
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
WO2009085879A2 (en) * 2007-12-21 2009-07-09 Schering Corporation C20-c21 substituted glucocorticoid receptor agonists
EP2235035A2 (de) * 2007-12-21 2010-10-06 Schering Corporation C-21-thioether als glucocorticoidrezeptoragonisten
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN102834406A (zh) 2009-06-16 2012-12-19 默沙东公司 作为糖皮质激素受体激动剂的新的[3.2-c]杂芳基甾体、其组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028400A (en) * 1962-04-03 Nsw steroid thioethers and process
US3105083A (en) * 1960-04-14 1963-09-24 Upjohn Co 21-organic sulfonates of 11, 17, 21-trioxygenated-3-keto pregnenes
US3171844A (en) * 1963-05-24 1965-03-02 Syntex Corp 20-(aliphatic hydrocarbonthio) and 20-(substituted aliphatic hydrocarbonthio) pregnane derivatives
FR2231374B1 (de) * 1973-05-30 1976-10-22 Jouveinal Sa
BE887518A (fr) * 1980-02-15 1981-08-13 Glaxo Group Ltd Cartothioates d'androstanes
FR2510582B1 (fr) * 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
FR2551069B1 (fr) * 1983-08-26 1986-07-25 Jouveinal Sa 17-oxo-21-thioesters d'hydrocortisone, leur preparation et leurs applications comme medicament
US4488995A (en) * 1984-02-06 1984-12-18 E. R. Squibb & Sons, Inc. Androstene-17β-alkylthiomethyl ethers

Also Published As

Publication number Publication date
JPS6289694A (ja) 1987-04-24
JPH0699468B2 (ja) 1994-12-07
DE3662896D1 (en) 1989-05-24
EP0208202A1 (de) 1987-01-14
EP0208202B1 (de) 1989-04-19
ES8707256A1 (es) 1987-07-16
US4861765A (en) 1989-08-29
ES556685A0 (es) 1987-07-16

Similar Documents

Publication Publication Date Title
ATE42306T1 (de) 21-substituierte thiosteroide.
AU565898B2 (en) 1,8-naphthyridine derivatives
AR241531A1 (es) Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables.
IE851205L (en) Beta-carbolines
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
TR22986A (tr) Halka hetero atomlari haiz bisiklo-heptanlar,oktanlar ve nonanlar,bunlarin hazirlanmasi ve pestibid olarak kullanimlari
IT1201481B (it) Pantotenil derivati
AU572888B2 (en) 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-i-yl-n- phenyl-acetamide derivatives
ATE90356T1 (de) 21-alkoxy-steroid-derivate.
DE3569380D1 (en) Pyridylphenylpyridazinone inotropic agents
ES8801669A1 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa-0 aza-pregnano.
GB2182328B (en) Diphenyl ether derivatives
FI903967A0 (fi) Nya imidazolderivat.
ATE21902T1 (de) 6-substituierte tetrahydroimidazo(2,1a)phthalazine.
DE3564937D1 (en) Novel substituted phenyl ethers, process for their preparation, and their use in the preparation of substituted phenols
AU2167588A (en) Diphenyl ether herbicides
ES8308875A1 (es) Procedimiento para preparar 4-aminometil-5-acil-1,3-dihidro-2h-imidazol-2-onas.
ES8308871A1 (es) Procedimiento para la preparacion de 4-(4-fenil-1-piperidinil) metil-5-acil-1,3-dihidro-2h-imidazol-2-onas.
DE3679224D1 (de) Carbacyclin-derivate.
ATE32340T1 (de) Substituierte tetrahydrotetrazolo(5,1a)phthalazine.
FI874677A7 (fi) Laekemedel anvaendbart vid behandling av magsaor.
DK504788A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
SU1314835A1 (ru) Вакуумный фоторезист
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
SU1037648A1 (ru) 3-Фенилвинил-5,6,7,8-тетрагидро-6,8-диметилпиримидо-[5,4-е] [1,2,4]-триазин-5, 7-дион, проявляющий противовоспалительную активность

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee